Price to Cash-Flow of OBI Pharma

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

Price to Cash-Flow analysis of OBI Pharma


 Price TWD  89.70
 Cahs-flow per share TWD  -5.57
 Capitalization (mn) TWD  11,813
 Free Cash-flow (mn) TWD  -1,047
 P/CF ratio -16.10
 OBI Pharma dividend
 OBI Pharma Price to book Value
 OBI Pharma Price to earnings
 OBI Pharma Return on Equity

OBI Pharma is a Health Care industry firm, which concentrates their activity in the Pharmaceuticals and Biotechnology sector. OBI Pharma headquarters are in Taiwan, where the firm is listed.

At the time of this analysis, OBI Pharma stocks were trading at a price of 89.70 TWD after collapsing their price by -42.30% last twelve months.

According to the graph below, where Price to cash-flow comparison chart is displayed, OBI Pharma, has a very negative P/CF ratio of -16.10, amount in contrast with the average P/CF of the market and companies from Taiwan, Health Care industry, and Pharmaceuticals and Biotechnology sector. This negative P/CF of OBI Pharma means the company had a huge outflow last year, so it is a must for the company to change their course of action in order to solve the problem. More OBI Pharma financial data can be accessed on the link.

Finally, you could draw a comparisson OBI Pharma P/CF with other Pharmaceuticals and Biotechnology companies or firms from Taiwan.

OBI Pharma price to earnings

Next companies

Obic. Japan. Technology.

Obic Business Consul. Japan. Technology.

OC Oerlikon Corp AG. Switzerland. Industrials.

Ocado Group. UK. Consumer Services.

Occidental Petroleum. USA. Oil and Gas.

OCI. Korea. Basic Materials.

Previous companies

Obayashi. Japan. Industrials.

OAO Gazprom. Russia. Oil and Gas.

O2 Czech Republic. Czeck Republic. Telecommunications.

O Reilly Auto. USA. Consumer Services.

NXP Semiconductors. USA. Technology.

NWS Holdings. Hong-Kong. Industrials.

All rights reserved

 information advertisement legal

Dividends Ranking | Price to BookValue | Price to Cash-Flow | Price to Earnings | Return on Equity

Disclaimer: Information on this site is only for informational purposes. Always consult a professional advisor before investing.